Neuropathological and Biomarker Findings in Parkinson’s Disease and Alzheimer’s Disease: From Protein Aggregates to Synaptic Dysfunction
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuropathological and Biomarker Findings in Parkinson’s Disease and Alzheimer’s Disease: From Protein Aggregates to Synaptic Dysfunction
Authors
Keywords
-
Journal
Journal of Parkinsons Disease
Volume -, Issue -, Pages 1-15
Publisher
IOS Press
Online
2020-12-09
DOI
10.3233/jpd-202323
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
- (2020) Ruwani S. Wijeyekoon et al. MOVEMENT DISORDERS
- Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment
- (2020) Weilin Liu et al. Translational Psychiatry
- Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
- (2020) Marta Milà‐Alomà et al. Alzheimers & Dementia
- Amyloid-β42/Neurogranin Ratio as a Potential Index for Cognitive Impairment in Parkinson’s Disease
- (2020) Giulia Maria Sancesario et al. JOURNAL OF ALZHEIMERS DISEASE
- NfL as a biomarker for neurodegeneration and survival in Parkinson disease
- (2020) David Bäckström et al. NEUROLOGY
- Long-term prognostic value of longitudinal measurements of blood neurofilament levels
- (2020) Dieter A. Häring et al. Neurology-Neuroimmunology & Neuroinflammation
- Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers
- (2020) Elisabetta Zucchi et al. Molecular Neurodegeneration
- CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD
- (2019) Kaj Blennow et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias
- (2019) Anna Antonell et al. Alzheimers & Dementia
- Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders
- (2019) Sara Hall et al. MOVEMENT DISORDERS
- Neurogranin as a predictor of memory and executive function decline in MCI patients
- (2018) Alison Headley et al. NEUROLOGY
- Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer’s disease
- (2018) Madhurima Chatterjee et al. Alzheimers Research & Therapy
- Lewy Body P:athology in Alzheimer's Disease: A Clinicopathological Prospective Study
- (2018) Rodolfo Savica et al. ACTA NEUROLOGICA SCANDINAVICA
- The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease
- (2018) Hlin Kvartsberg et al. ACTA NEUROPATHOLOGICA
- α-Synuclein in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment
- (2018) Ane Korff et al. JOURNAL OF ALZHEIMERS DISEASE
- Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort
- (2017) G. G. Kovacs et al. EUROPEAN JOURNAL OF NEUROLOGY
- Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis
- (2017) David J Irwin et al. LANCET NEUROLOGY
- Levodopa treatment and dendritic spine pathology
- (2017) Haruo Nishijima et al. MOVEMENT DISORDERS
- Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers
- (2017) Kaitlin B. Casaletto et al. NEUROLOGY
- Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics
- (2017) N.K. Magdalinou et al. PARKINSONISM & RELATED DISORDERS
- Small-molecule PET Tracers for Imaging Proteinopathies
- (2017) Chester A. Mathis et al. SEMINARS IN NUCLEAR MEDICINE
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case
- (2017) Marta Marquié et al. Acta Neuropathologica Communications
- CSF α-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease
- (2017) Fransje E. Reesink et al. JOURNAL OF ALZHEIMERS DISEASE
- Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia
- (2016) Erika Bereczki et al. Alzheimers & Dementia
- Characterization of tau positron emission tomography tracer [ 18 F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias
- (2016) Kerstin Sander et al. Alzheimers & Dementia
- AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies
- (2016) Kejal Kantarci et al. ANNALS OF NEUROLOGY
- Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study
- (2016) Guro Berge et al. BMC Neurology
- Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson’s Disease1
- (2016) Mariateresa Buongiorno et al. JOURNAL OF ALZHEIMERS DISEASE
- Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer′s and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies
- (2016) Patrick Oeckl et al. MOLECULAR & CELLULAR PROTEOMICS
- Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins
- (2016) Steffen Halbgebauer et al. MOVEMENT DISORDERS
- Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum
- (2016) M. Sierra et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
- (2016) Annika Öhrfelt et al. Alzheimers Research & Therapy
- Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases
- (2016) Stephen N. Gomperts et al. JAMA Neurology
- Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
- (2016) Graham Fairfoul et al. Annals of Clinical and Translational Neurology
- Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer’s disease
- (2015) Chengyu Zou et al. ACTA NEUROPATHOLOGICA
- Analyzing dendritic spine pathology in Alzheimer’s disease: problems and opportunities
- (2015) Mario M. Dorostkar et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
- (2015) Hlin Kvartsberg et al. Alzheimers & Dementia
- Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
- (2015) Konstantin Hellwig et al. Alzheimers Research & Therapy
- Intracellular amyloid β oligomers impair organelle transport and induce dendritic spine loss in primary neurons
- (2015) Tomohiro Umeda et al. Acta Neuropathologica Communications
- Increased CSF α-synuclein levels in Alzheimer's disease: Correlation with tau levels
- (2014) Sylvie Slaets et al. Alzheimers & Dementia
- Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort
- (2014) Tessandra Stewart et al. AMERICAN JOURNAL OF PATHOLOGY
- Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits
- (2014) Eric C. Miller et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson’s disease
- (2014) Yaroslau Compta et al. JOURNAL OF NEUROLOGY
- CSF A 42 predicts early-onset dementia in Parkinson disease
- (2014) G. Alves et al. NEUROLOGY
- CSF biomarkers and clinical progression of Parkinson disease
- (2014) S. Hall et al. NEUROLOGY
- Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
- (2014) Oskar Hansson et al. Alzheimers Research & Therapy
- CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- The dendritic hypothesis for Alzheimer's disease pathophysiology
- (2013) J. Nicholas Cochran et al. BRAIN RESEARCH BULLETIN
- Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
- (2013) Jing L. Guo et al. CELL
- Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
- (2013) David J. Irwin et al. NATURE REVIEWS NEUROSCIENCE
- The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinson's Disease Progression and Related Dementia
- (2013) Yaroslau Compta et al. Neurodegenerative Diseases
- Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study
- (2013) Yaroslau Compta et al. PARKINSONISM & RELATED DISORDERS
- β-Amyloid oligomers in aging and Alzheimer’s disease
- (2013) Kathleen R. Zahs et al. Frontiers in Aging Neuroscience
- Amyloid plaque formation precedes dendritic spine loss
- (2012) Tobias Bittner et al. ACTA NEUROPATHOLOGICA
- Neuropathologic substrates of Parkinson disease dementia
- (2012) David J. Irwin et al. ANNALS OF NEUROLOGY
- Pathologic Accumulation of α-Synuclein and Aβ in Parkinson Disease Patients With Dementia
- (2012) Paul T. Kotzbauer et al. ARCHIVES OF NEUROLOGY
- Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
- (2012) S. N. Gomperts et al. NEUROLOGY
- Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia
- (2012) Yaroslau Compta et al. PARKINSONISM & RELATED DISORDERS
- Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
- (2011) Y. Compta et al. BRAIN
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Does levodopa accelerate the pathologic process in Parkinson disease brain?
- (2011) L. Parkkinen et al. NEUROLOGY
- The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
- (2010) Walter J. Schulz-Schaeffer ACTA NEUROPATHOLOGICA
- Progressive accumulation of amyloid-β oligomers in Alzheimer’s disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins
- (2010) Emiley Pham et al. FEBS Journal
- Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease
- (2010) Isidre Ferrer et al. JOURNAL OF NEURAL TRANSMISSION
- Synergistic Interactions between A , Tau, and -Synuclein: Acceleration of Neuropathology and Cognitive Decline
- (2010) L. K. Clinton et al. JOURNAL OF NEUROSCIENCE
- CSF Aβ42and tau in Parkinson's disease with cognitive impairment
- (2010) Thomas J. Montine et al. MOVEMENT DISORDERS
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- Parkinson Disease With Dementia
- (2009) Marwan N. Sabbagh et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease
- (2009) Yaroslau Compta et al. MOVEMENT DISORDERS
- In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia
- (2009) M. A. Burack et al. NEUROLOGY
- Co-localization of tau and α-synuclein in the olfactory bulb in Alzheimer’s disease with amygdala Lewy bodies
- (2008) Hiroshige Fujishiro et al. ACTA NEUROPATHOLOGICA
- Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
- (2008) Kurt A. Jellinger et al. ACTA NEUROPATHOLOGICA
- Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson’s disease patients
- (2008) Tammaryn Lashley et al. ACTA NEUROPATHOLOGICA
- The progression of pathology in longitudinally followed patients with Parkinson’s disease
- (2008) Glenda Halliday et al. ACTA NEUROPATHOLOGICA
- CSF α-synuclein levels in dementia with Lewy bodies and Alzheimer's disease
- (2008) Moeko Noguchi-Shinohara et al. BRAIN RESEARCH
- Widespread Changes in Dendritic Spines in a Model of Alzheimer's Disease
- (2008) S. Knafo et al. CEREBRAL CORTEX
- Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
- (2008) P Edison et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Striatal β-Amyloid Deposition in Parkinson Disease With Dementia
- (2008) Michail E. Kalaitzakis et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Why Alzheimer’s is a disease of memory: The attack on synapses by Aß oligomers (ADDLs)
- (2008) K. L. Viola et al. Journal of Nutrition Health & Aging
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Imaging amyloid deposition in Lewy body diseases
- (2008) S. N. Gomperts et al. NEUROLOGY
- Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?
- (2008) Annika Öhrfelt et al. NEUROSCIENCE LETTERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started